Servicio de Neumología, IIS-Fundación Jiménez Díaz - ISCIII-CIBERES, Madrid, Spain.
Int Braz J Urol. 2020 Jul;46(suppl.1):125-132. doi: 10.1590/S1677-5538.IBJU.2020.S118.
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2.
由严重急性呼吸系统综合症冠状病毒 2 型（SARS-CoV-2）引起的 2019 年冠状病毒病（COVID-19）是这一代人面临的最重大的全球公共卫生危机。从疫情开始，就已经有关于不同治疗方案的出版物和在线资源，针对 COVID-19 疫情开展的调查潜在疗法的工作力度也是空前的。不幸的是，到目前为止，还没有足够的证据推荐任何特定的抗 COVID-19 治疗方法。即使在大流行期间，也需要随机临床试验和高质量的证据。我们回顾了关于 SARS-CoV-2 的治疗策略和当前研究方向的最新已发表文献。
